Long-term protection against carriage of hepatitis B virus after infant vaccination.
about
Reasons why West Africa continues to be a hotbed for hepatocellular carcinomaHepatitis B and the need for a booster dosePartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescenceHost genetic factors and vaccine-induced immunity to hepatitis B virus infection.Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysisHepatitis B virus: where do we stand and what is the next step for eradication?Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism.The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccinationProblem of hepatocellular carcinoma in West AfricaEfficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation programNo evidence for occult HBV infection in hepatitis B vaccine non-responders.The necessity of booster vaccination after neonatal hepatitis B vaccination.Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screeningThe one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia.Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea GovernorateClinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.Immune persistence after hepatitis B vaccination in infancy - Fact or fancy?Potential role of killer immunoglobulin receptor genes among individuals vaccinated against hepatitis B virus in Lebanon.Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand.Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody.Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.Effectiveness of individual-focused interventions to prevent chronic disease.Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.Long-term persistence of immunity after hepatitis B vaccination: Is this substantiated by the literature?HBV carriage in children born from HIV-seropositive mothers in Senegal: The need of birth-dose HBV vaccination.Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.Unsolved problems and future perspectives of hepatitis B virus vaccination.Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.The presence of hepatitis B surface antigen in the ova of pregnant women and its relationship with intra-uterine infection by hepatitis B virus.The status of hepatitis B control in the African region.
P2860
Q26772209-A6AC8EA8-E735-4140-A784-1AEF69D0937CQ28239937-FD3231F6-51EF-4511-8439-B1B504CEC39AQ28742762-DB6D172F-F630-4399-8061-1CA02097A0E1Q33294724-CAC007BF-6616-49DB-B9FD-79FBB6AA411FQ33325499-4B6E23E2-3A78-4F73-B26C-5675FECF831FQ33678959-F6C0D5F9-7F6E-47EB-A7FA-CD790B37FE8DQ33958764-63548B1E-6AC7-4E9D-82BA-51A1C2ED3441Q34098741-A135B7F2-5D48-483F-BCAC-0E61D1AFD6F2Q34289256-E2B801CF-2D50-4249-B6B4-9B1867D4D9DBQ34425952-D7DFCBAF-0D02-4C42-8708-D702753B90C4Q34567959-84F80900-2F87-4888-8D67-57DEC1D42204Q35084497-224D2E3B-9745-4A16-BDB5-07AD9047144DQ35270769-7776B05F-50B9-4F8E-9BCD-F96F95EDD928Q35540277-B981323C-6181-45DB-B068-08A5D8A481BFQ35579913-89162E89-DB1A-4A9B-919F-D7319ADA6A75Q35584844-2CB884D3-21A2-4AF9-BE33-5D4A8BC6B575Q35886836-49C41880-52A3-4E49-8D2F-761AD14F1257Q36131759-77CC25BF-A151-4C8A-863B-CA1B7655E02BQ36138640-E1478368-ECA3-45A9-9751-419E8FD69690Q36552883-846BE9CB-1786-420D-9437-A196C0D71EC8Q36606605-0591283F-23D0-4E1C-BA0A-3A9B30C220C1Q37006564-F73273BD-3446-4DDB-B8D1-BD393FAAA93AQ37107195-535DADCD-78DE-41D3-B5A5-996BB795FBEDQ37131019-CBF0309A-C085-47BF-90CF-9B75BC03DC8AQ37345255-5D87633A-E4AD-42C8-97D8-00284D6C7CD6Q37530077-51FAAA9A-2993-43B9-8C72-B89AF9D1F30FQ37606206-C9E953F4-300D-43E9-AB23-0FF2A009217CQ38211738-C2740A30-2B5C-4CF1-BAC4-26A9603D9EBFQ38231641-FA9B1DDA-87DF-4EFC-8D5D-3DE38D7CA055Q39457688-46553BB3-CDF9-47A7-90BA-BAB4A51916B4Q39812218-D8752DDE-3EBF-4FAD-9512-058A202E7AEBQ40057020-830614A7-4A8B-4B3E-A097-DA59AFDEDBFDQ40300417-57FCCD4D-0FB2-460E-A9DF-961D1FD0D66CQ40942366-FA44193F-34E1-47F2-9C75-2165EB687B06Q40992209-92F514F9-721D-4BA3-A1FE-325C7D23D98FQ42412334-DE1B07C9-FA1E-4D3C-A218-E986A3BD036BQ43640407-8B30575B-1664-422B-804D-356FDF90AF94Q44525165-FD396234-38F9-44A9-BEAD-30C11485A30CQ45377987-79A2AD2C-4F97-460F-983E-0F8594035B0DQ47158580-7FBEE78E-2746-4A63-BFA5-835400AE539E
P2860
Long-term protection against carriage of hepatitis B virus after infant vaccination.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@en
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@nl
type
label
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@en
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@nl
prefLabel
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@en
Long-term protection against carriage of hepatitis B virus after infant vaccination.
@nl
P2093
P356
P1476
Long-term protection against carriage of hepatitis B virus after infant vaccination
@en
P2093
D Jeffries
H C Whittle
P Rayco-Solon
P304
P356
10.1086/503433
P407
P577
2006-04-25T00:00:00Z